Report Wire

Tag: pharma sector news

  • Cipla Q1 web revenue dips marginally to Rs 706 crore

    Drug main Cipla on Friday posted a marginal decline in its consolidated web revenue to Rs 706 crore for the primary quarter ended on June 30, 2022.

    The Mumbai-based firm had reported a web revenue of Rs 710 crore within the April-June quarter of the final fiscal.

    Total income from operations declined to Rs 5,375 crore within the June quarter as in contrast with Rs 5,504 crore within the year-ago interval, Cipla mentioned in a regulatory submitting.

    Shares of the corporate ended 1.08 per cent up at Rs 978.15 apiece on the BSE.

    TWO IS ALWAYS BETTER |
    Our two-year subscription bundle provides you extra at much less

  • Dilip Shanghvi resigns as MD of SPARC

    Sun Pharma Advanced Research Company (SPARC) on Tuesday mentioned Dilip Shanghvi has resigned as managing director of the corporate.
    Shanghvi expressed his want to step down and tendered his resignation because the MD with speedy impact, which was accepted by the board, SPARC mentioned in a regulatory submitting.
    Shanghvi will, nonetheless, proceed to be related to the corporate’s board in his capability as a non-executive director and chairman, it added.

    It additional said that the board, on the advice of Nomination and Remuneration Committee, has appointed Anil Raghavan as chief government officer (CEO) of the corporate with speedy impact for a time period of 5 years until May 24, 2026.

    Prior to becoming a member of SPARC, Raghavan served because the managing director of the India and Sri Lanka enterprise of Quintiles, a worldwide pharmaceutical providers firm.
    SPARC was shaped in 2007 by a demerger from drug main Sun Pharma.